UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy

Nature reviews. Cancer, 2018-06, Vol.18 (6), p.341-358

2018

Volltextzugriff (PDF)

MET signalling: principles and functions in development, organ regeneration and cancer

Nature reviews. Molecular cell biology, 2010-12, Vol.11 (12), p.834-848

2010

Volltextzugriff (PDF)

Drug development of MET inhibitors: targeting oncogene addiction and expedience

Nature reviews. Drug discovery, 2008-06, Vol.7 (6), p.504-516

2008

Volltextzugriff (PDF)

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

International journal of molecular sciences, 2019-05, Vol.20 (9), p.2164

2019

Volltextzugriff (PDF)

Inteligencia artificial y selección de pruebas en el proceso civil: ¿hacia un proceso más inteligente o hacia un proceso más artificial?

Revista Ítalo-Española de Derecho Procesal, 2022-09, p.1-29

Comoglio, Paolo

2022

Volltextzugriff (PDF)

Invasive growth: a MET -driven genetic programme for cancer and stem cells

Nature reviews. Cancer, 2006-08, Vol.6 (8), p.637-645

2006

Volltextzugriff (PDF)

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

The lancet oncology, 2016-06, Vol.17 (6), p.738-746

2016

Volltextzugriff (PDF)

The Met tyrosine kinase receptor in development and cancer

Cancer and metastasis reviews, 2008-03, Vol.27 (1), p.85-94

2008

Volltextzugriff (PDF)

The MET receptor tyrosine kinase in invasion and metastasis

Journal of cellular physiology, 2007-11, Vol.213 (2), p.316-325

2007

Volltextzugriff (PDF)

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk

International journal of molecular sciences, 2018-12, Vol.19 (12), p.3920

2018

Volltextzugriff (PDF)

Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer

JNCI : Journal of the National Cancer Institute, 2011-04, Vol.103 (8), p.645-661

2011

Volltextzugriff (PDF)

The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (11), p.3193-3199

2013

Volltextzugriff (PDF)

MET, a driver of invasive growth and cancer clonal evolution under therapeutic pressure

Current opinion in cell biology, 2014-12, Vol.31, p.98-105

2014

Volltextzugriff (PDF)

MET-Mediated Resistance to EGFR Inhibitors: An Old Liaison Rooted in Colorectal Cancer Stem Cells

Cancer research (Chicago, Ill.), 2014-07, Vol.74 (14), p.3647-3651

2014

Volltextzugriff (PDF)

MET Signaling in Colon Cancer Stem-like Cells Blunts the Therapeutic Response to EGFR Inhibitors

Cancer research (Chicago, Ill.), 2014-03, Vol.74 (6), p.1857-1869

2014

Volltextzugriff (PDF)

An Observatory for the MET Oncogene: A Guide for Targeted Therapies

Cancers, 2023-09, Vol.15 (18), p.4672

2023

Volltextzugriff (PDF)

Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8), p.3132-3141

2011

Volltextzugriff (PDF)

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Cancer cell, 2003-04, Vol.3 (4), p.347-361

2003

Volltextzugriff (PDF)

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (40), p.10058-10063

2018

Volltextzugriff (PDF)

Genetic Evolution of Glioblastoma Stem‐Like Cells From Primary to Recurrent Tumor

Stem cells (Dayton, Ohio), 2017-11, Vol.35 (11), p.2218-2228

2017

Volltextzugriff (PDF)

Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody‐“decoy” strategy

International journal of cancer, 2018-10, Vol.143 (7), p.1774-1785

2018

Volltextzugriff (PDF)

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

Nature reviews. Cancer, 2002-04, Vol.2 (4), p.289-300

2002

Volltextzugriff (PDF)

The Met oncogene and basal-like breast cancer: another culprit to watch out for?

Breast cancer research : BCR, 2010-01, Vol.12 (4), p.208-208, Article 208

2010

Volltextzugriff (PDF)

The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype

Cancer research (Chicago, Ill.), 2012-09, Vol.72 (17), p.4537-4550

2012

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(382)
Mit Volltextzugriff
(387)

Publikationsform

Artikel
(410)
Buchkapitel
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(284)
Life Sciences & Biomedicine
(266)
Humans
(205)
Animals
(185)
Mice
(120)
Oncology
(119)
Biological And Medical Sciences
(97)
Cell Biology
(91)
Biochemistry & Molecular Biology
(84)
Tumors
(73)
Signal Transduction
(68)
Phosphorylation
(65)
Proto-Oncogene Proteins C-Met - Metabolism
(61)
Female
(60)
Proto-Oncogene Proteins C-Met - Genetics
(58)
Cell Line
(57)
Proto-Oncogene Proteins C-Met
(57)
Medical Sciences
(50)
Fundamental And Applied Biological Sciences. Psychology
(49)
Cell Line, Tumor
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy

MET signalling: principles and functions in development, organ regeneration and cancer

Drug development of MET inhibitors: targeting oncogene addiction and expedience

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

Inteligencia artificial y selección de pruebas en el proceso civil: ¿hacia un proceso más inteligente o hacia un proceso más artificial?

Invasive growth: a MET -driven genetic programme for cancer and stem cells

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

The Met tyrosine kinase receptor in development and cancer

The MET receptor tyrosine kinase in invasion and metastasis

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk

Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer

The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target

MET, a driver of invasive growth and cancer clonal evolution under therapeutic pressure

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer

MET-Mediated Resistance to EGFR Inhibitors: An Old Liaison Rooted in Colorectal Cancer Stem Cells

MET Signaling in Colon Cancer Stem-like Cells Blunts the Therapeutic Response to EGFR Inhibitors

An Observatory for the MET Oncogene: A Guide for Targeted Therapies

Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation

Genetic Evolution of Glioblastoma Stem‐Like Cells From Primary to Recurrent Tumor

Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody‐“decoy” strategy

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

The Met oncogene and basal-like breast cancer: another culprit to watch out for?

The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype

Suchergebnisse filtern